Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen

This publication has 29 references indexed in Scilit:

• Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
  Blood, 2002
• Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
  New England Journal of Medicine, 2002
• Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
  British Journal of Haematology, 2002
• Clinical efficacy of echinocandin antifungals
  Current Opinion in Infectious Diseases, 2001
• Use of Real‐Time PCR on Blood Samples for Diagnosis of Invasive Aspergillosis
  Clinical Infectious Diseases, 2001
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
  Blood, 2001
• Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation
  Clinical Infectious Diseases, 1999
• Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
  Blood, 1998
• Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation
  The Journal of Infectious Diseases, 1997
• Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
  New England Journal of Medicine, 1991